Correlation between clinical response to interleukin 2 and HLA phenotypes in patients with metastatic renal cell carcinoma.

HLA phenotypes were characterized for 79 patients with metastatic renal cell carcinoma treated with interleukin 2 (IL-2). HLA-A32 was associated with a clinical response (P = 0.025). The frequency of HLA-A3 and/or A32 was higher among responders than non-responders (P = 0.008). Thus, these results s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bain, C., Merrouche, Y., Puisieux, I., Blay, J. Y., Negrier, S., Bonadona, V., Lasset, C., Lanier, F., Duc, A., Gebuhrer, L., Philip, T., Favrot, M. C.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063266/
https://www.ncbi.nlm.nih.gov/pubmed/9010039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063266/
https://www.ncbi.nlm.nih.gov/pubmed/9010039

Ejemplares similares